Buried in the Lialda agreement is a 'change in control' clause that reverts Lialda back to Cosmo. Salix just did a deal with Cosmo that gives them first right of refusal to sell any Cosmo GI drug that becomes available. Lialda is as good as gone now.
Get your resumes ready!! There is no way Salix will license "Lialda" to anyone other than a contract sales force. Abbvie should ave done their research a little better and purchased Cosmo first and then Shire.
Pretty sure Abbvie doesn't want to buy Shire for Lialda. Do your research, it's a tax inversion purchase.